Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib in Relapsed or Refractory Diffuse Large Cell Lymphoma
NCT00511043Phase 2Terminated
- Start
- Nov 2005
- Primary completion
- Aug 2009
- Countries
- 1
01
Overview
Phase 2, open-label trial of vatalanib in diffuse large B-cell lymphoma (DLBCL). Primary endpoint: Response at 1 year. Started Nov 2005; status: terminated.
02
Drugs
vatalanib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00511043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00511043.